Exclusive

Publication

Byline

Clinical Trial: Safety and Dystrophin Expression of SPOT-mRNA03 in Duchenne Muscular Dystrophy (DMD) Patients

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07188012) titled 'Safety and Dystrophin Expression of SPOT-mRNA03 in Duchenne Muscular Dystrophy (DMD) Patie... Read More


Clinical Trial: TR-002 for the Treatment of Advanced, Unresectable or Metastatic Solid Tumors and Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07189195) titled 'TR-002 for the Treatment of Advanced, Unresectable or Metastatic Solid Tumors and Unresect... Read More


Clinical Trial: Comparing Muscle Energy Technique and Bowen Therapy for Pain, Movement, and Disability in Text Neck Syndrome

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07189351) titled 'Comparing Muscle Energy Technique and Bowen Therapy for Pain, Movement, and Disability in ... Read More


Clinical Trial: The Effects of a Meditation Intervention on the Psychological Burden of Long-Term Care Professionals and Family Caregivers

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07188454) titled 'The Effects of a Meditation Intervention on the Psychological Burden of Long-Term Care Pro... Read More


Clinical Trial: EVALUATION OF A FULLY AUTOMATED AI TOOL FOR EMBRYO RANKING

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07187934) titled 'EVALUATION OF A FULLY AUTOMATED AI TOOL FOR EMBRYO RANKING' on Sept. 04. Brief Summary: T... Read More


Clinical Trial: Mass Spectrometry-based Immune Profiling in Autoimmune Diseases

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07188285) titled 'Mass Spectrometry-based Immune Profiling in Autoimmune Diseases' on April 14. Brief Summa... Read More


Clinical Trial: Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression: the Prospective VASCUL-AID Study

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07187700) titled 'Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disea... Read More


Clinical Trial: Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin.

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07188441) titled 'Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Inje... Read More


Clinical Trial: The Neoadjuvant Treatment of Early High-risk Triple Negative Breast Cancer With HRD Positive With Iparomlimab and Tuvonralimab Combined With Olaparib and Paclitaxel

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07187674) titled 'The Neoadjuvant Treatment of Early High-risk Triple Negative Breast Cancer With HRD Positi... Read More


Clinical Trial: A Randomized Phase 2 Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07188896) titled 'A Randomized Phase 2 Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus N... Read More